Travere Therapeutics, Inc. (TVTX) NASDAQ

15.32

+0.6(+4.08%)

Updated at June 06 04:00PM

Currency In USD

Valuation

Market Cap1.37B
Enterprise Value1.72B
P/E Ratio-5.97
PEG Ratio-0.19
Price/Sales Ratio4.97
Price/Book Ratio41.24
Enterprise/Revenue6.21
Enterprise/EBITDA-10.1

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-0.83
Operating Margin-0.82

Management Effectiveness

Return On Assets-0.41
Return On Equity-11.84

Income Statement

Revenue233.18M
Revenue/Share3.1
Gross Profit225.43M
EBITDA-265.77M
Net Income-321.55M
Diluted EPS-4.08

Balance Sheet

Total Cash322.24M
Total Cash/Share3.65
Total Debt400.46M
Total Debt/Equity12.2
Current Ratio2.05
Book Value Per Share0.37

Price History

52-Week Change110.73
52-Week High25.29
52-Week Low6.8
Moving Average 50 Days17.3
Moving Average 200 Days17.51

Statistics

Average Volume1.78M
Shares Outstanding88.8M
% Held by Institutions110.92

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:9
Last Split DateNovember 02, 2012